Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used With Targeted Radiation-based Treatment (Lutetium Lu 177 Dotatate), Compared to Lutetium Lu 177 Dotatate Alone for Metastatic Neuroendocrine Tumors
Clinical trial NCT05724108 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05724108
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-30
- Primary completion
- 2026-12-09
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.